USA> Israel based equity crowdsourcing platform OurCrowd and USA based 7thirty Capital is set to launch $30 million fund to invest in cannabis tech

OurCrowd_logo Partnering with 7thirty Capital, Israel based OurCrowd is set to launch $30 million fund to invest in cannabis tech. Set to be based in Boulder, Colorado, USA, the newly established fund will focus on emerging cannabis technology companies in med-tech, ag-tech, retail, e-commerce and marketplaces. The fund is set to be active globally and will include countries such as Israel, More …

ITALY > USA based Catalent Pharma Solutions is set to invest $7.3 million on its Aprilia, Italy facility

Catalent logo One of the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, Catalent Pharma Solutions is set to invest $7.3 million to upgrade and expand its packaging and softgel encapsulation capabilities at its facility in Aprilia, Italy. The investment is divided in phases and in the first phase of the investment, the More …

SINGAPORE > China based Yifan Pharmaceutical Co. is set to acquire 90% of Singapore based biopharmaceutical company SciGen Ltd

yigan logo China based Yifan Pharmaceutical Co. is set to acquire Singapore based biopharmaceutical company SciGen Ltd for approximately $28 million for $0.05 a share to acquire at least 90% of SciGen which is listed in the Australian Stock Exchange. The full takeover would value SciGen at $28 million. Yifan has signed an agreement with SciGen’s controlling shareholder Bioton SA that owns More …

CANADA > USA based Constellation Brands Inc. parent company of Corona beer is set to invest $4 billion in Canada based pot producer Canopy Growth Corp

Constellation Brand US based Constellation Brands Inc. is set to buy 104.5 million shares worth $4 billion in Canopy Growth Corp. With the latest round of investment, Constellation Brands Inc. stake in Canopy Growth Corp. will be 38 percent. The investment is the largest in the cannabis sector by Constellation after its investment in Canopy last October. According to Linda Montag, senior More …

USA > JAPAN based Otsuka Pharmaceutical is set to acquire USA based Visterra for approximately $430 million

otsuka logo In an all cash transaction, Japan based Otsuka Pharmaceutical is set to acquire USA based Visterra Inc. for approximately $430 million. The transaction has been approved by boards of directors of both companies and the deal is subject to customary closing conditions, including expiration or termination of the waiting period under U.S. antitrust laws and is expected to close in More …

USA > UK based Eli Lilly is set to acquire USA based ARMO BioSciences for $1.6 billion

Eli Lilly logo For $50 per share or approximate value of $1.6 billion, UK based Eli Lilly is all set to acquire USA based ARMO BioSciences. ARMO BioSciences is a company that is working on a late stage immune oncology that is developing a pipeline of novel, proprietary product candidates that is designed to activate the immune system of cancer patients to recognize More …

USA > Switzerland based Novartis is set to acquire USA based AveXis Inc. for $8.7 billion

Novartis logo To transform care in SMA and expand its position as a gene therapy and Neuroscience leader, Novartis is set to acquire AveXis Inc. for $8.7 billion. AVXS-101, AveXis lead product candidate, has the potential to be the first ever one time gene replacement therapy for spinal muscular atrophy (SMA). SMA is a disease that results in either early death or More …

​CANADA > France based Sanofi is set to invest €350 million($433.18 million) in Canadian vaccine facility

Sanofi logo For the construction of a new state of the art vaccine manufacturing facility, Sanofi is investing €350 million($433.18 million) at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario, Canada. Demonstrating Sanofi’s commitment to innovation and leadership in global public health, the investment bolsters Sanofi’s Canada operations. The new investment is the largest ever investment by Sanofi in a single building More …